Intra-Cellular Therapies, Inc. announced the appointment of E. Rene Salas to the Intra-Cellular Therapies Board of Directors. Mr. Salas will serve as a member of the audit committee.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
73.46 USD | +0.28% | -1.50% | +2.52% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.52% | 7.72B | |
-4.06% | 86.13B | |
+1.97% | 39.82B | |
+56.59% | 25.23B | |
-13.79% | 15.36B | |
-8.82% | 11.95B | |
-15.74% | 11.6B | |
-41.58% | 11.51B | |
+6.14% | 8.71B | |
-7.02% | 8.12B |
- Stock Market
- Equities
- ITCI Stock
- News Intra-Cellular Therapies, Inc.
- Intra-Cellular Therapies Announces Appointment of E. Rene Salas to Board of Directors and as A Member of the Audit Committee